Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis
Journal article, 2006
Survival Rate
Probability
Neoplastic
Gene Deletion
Adult
Humans
Biological
*Mutation
Proto-Oncogene Proteins c-kit/*genetics
Exons/genetics
Retrospective Studies
Gastrointestinal Stromal Tumors/*genetics/*mortality/therapy
Platelet-Derived Growth Factor alpha/*genetics
DNA Mutational Analysis
Female
Aged
Cohort Studies
Receptor
Male
Sensitivity and Specificity
Middle Aged
Gene Expression Regulation
Tumor Markers
Risk Assessment
Prognosis
Missense
Author
Johanna Andersson
University of Gothenburg
Per Bümming
University of Gothenburg
Jeanne Meis-Kindblom
University of Gothenburg
H. Sihto
Helsinki University Central Hospital
N. Nupponen
Helsinki University Central Hospital
H. Joensuu
Helsinki University Central Hospital
Anders Odén
Chalmers, Mathematical Sciences
University of Gothenburg
B. Gustavsson
Novartis Oncology
Lars-Gunnar Kindblom
University of Gothenburg
Bengt E Nilsson
University of Gothenburg
Gastroenterology
0016-5085 (ISSN) 1528-0012 (eISSN)
Vol. 130 6 1573-81Subject Categories
MEDICAL AND HEALTH SCIENCES
DOI
10.1053/j.gastro.2006.01.043
PubMed
16697720